Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: Journal of Medical Internet Research (no longer under consideration since Aug 13, 2026)

Date Submitted: Aug 3, 2026
Open Peer Review Period: Aug 13, 2026 - Aug 13, 2026
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Cardiotoxicity Associated With Quinolone Antibiotics: A Cross-National Real-World Data-Mining Study Using FAERS and JADER

  • Lu Zhou; 
  • Yan Zhou; 
  • Chun Liu; 
  • Yun Lu; 
  • Ya Zou; 
  • Hua Wei; 
  • Shibo Lin; 
  • Xirui Guo; 
  • Qinchuan Li; 
  • Fangqing Xie; 
  • Hongju Wang; 
  • Shihao Yan; 
  • Jia Chen

ABSTRACT

Background:

Fluoroquinolones are widely prescribed broad-spectrum antibiotics whose cardiotoxic potential extends beyond QT-interval prolongation and arrhythmias, but a systematic, cross-national comparison of quinolone-associated cardiac adverse events (cAEs) profile using large-scale real-world data has been lacking.

Objective:

This study aims to jointly mine two independent pharmacovigilance databases to characterize the full spectrum of fluoroquinolone-associated cardiac adverse event signals and identify which individual agents diverge from the class-wide QT/torsade de pointes (TdP) pattern.

Methods:

This study analyzed cAEs associated with fluoroquinolones using the FDA Adverse Event Reporting System (FAERS) and the Japanese Adverse Drug Event Report database (JADER) from Jan 01, 2016-Dec 31, 2025. Disproportionate reporting was assessed using the reporting odds ratio (ROR) and proportional reporting ratio (PRR) for individual Preferred Terms, along with time-to-onset (TTO) and demographic subgroup analyses.

Results:

After deduplication, a total of 2,864 cAE reports in FAERS and 248 cAE reports in JADER were identified. Ciprofloxacin (48.5%), levofloxacin (25.9%), moxifloxacin (18.7%), and ofloxacin (0.7%) accounted for the great majority of FAERS cAE reports; levofloxacin (65.3%) and enoxacin (23.8%) predominated in JADER. Levofloxacin showed significant signals for long QT syndrome in FAERS (ROR 23.16, 95% CI 16.41–32.71) and for electrocardiogram QT prolonged in JADER (ROR 6.78, 95% CI 5.34–8.59); moxifloxacin showed significant signals for torsade de pointes (TdP) in FAERS (ROR 15.27, 95% CI 9.72–23.98) and electrocardiogram QT prolonged in JADER (ROR 9.62, 95% CI 4.25–21.74). Pazufloxacin, reported only in JADER, showed an exceptionally high but case-limited TdP signal (ROR 151.90, 95% CI 46.38–497.54, based on 12 total reports). Ciprofloxacin displayed a distinct signal profile dominated by structural and autonomic phenotypes, including postural orthostatic tachycardia syndrome (ROR 59.14, 95% CI 44.73–78.21) and valve-thickening signals. Elderly patients were disproportionately represented, particularly in JADER, where 61.3% of cAE cases occurred in patients aged ≥70 years. Fluoroquinolone-associated cAEs had a median time to onset of 3.0 days (IQR 0.0–14.0) in FAERS and 2.0 days (IQR 0.0–7.0) in JADER , with no statistically significant cross-database difference (Wilcoxon test, P=0.840), with over 80% of FAERS events occurring within the first 15 days of therapy. Crude case-fatality was 5.0% in FAERS and 8.9% in JADER.

Conclusions:

Fluoroquinolone-associated cardiotoxicity extends beyond QT prolongation to structural, ischemic, and autonomic phenotypes, with signal patterns that differ by agent and by population. Although disproportionality analysis cannot establish causality, these findings are hypothesis-generating and support vigilant cardiac monitoring — particularly during the early days of therapy and in elderly patients — pending confirmation in prospective studies. Clinical Trial: Not applicable.


 Citation

Please cite as:

Zhou L, Zhou Y, Liu C, Lu Y, Zou Y, Wei H, Lin S, Guo X, Li Q, Xie F, Wang H, Yan S, Chen J

Cardiotoxicity Associated With Quinolone Antibiotics: A Cross-National Real-World Data-Mining Study Using FAERS and JADER

JMIR Preprints. 03/08/2026:108514

DOI: 10.2196/preprints.108514

URL: https://preprints.jmir.org/preprint/108514

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.